Fibrosis indexes reduce the need of liver biopsy in chronic hepatitis C
Björklund, J.; Aleman, S.; Weiland, O.
Lakartidningen 106(14): 1016-1019
2009
ISSN/ISBN: 0023-7205 PMID: 19485036 Document Number: 630577
Document emailed within 1 workday
Related Documents
Vardar, R.; Vardar, E.; Demiri, S.; Sayhan, S.E.; Bayol, U.; Yildiz, C.şk.; Postaci, H. 2009: Is there any non-invasive marker replace the needle liver biopsy predictive for liver fibrosis, in patients with chronic hepatitis? Hepato-Gastroenterology 56(94-95): 1459-1465Awad, M.E.-D.A.E.-A.; Shiha, G.E.; Sallam, F.A.; Mohamed, A.; El Tawab, A. 2013: Evaluation of liver stiffness measurement by fibroscan as compared to liver biopsy for assessment of hepatic fibrosis in children with chronic hepatitis C Journal of the Egyptian Society of Parasitology 43(3): 805-819
Takashima, T.; Iijma, H.; Nishiguchi, S. 2015: Diagnosis of liver fibrosis in patients with chronic hepatitis using serum enhanced liver fibrosis (ELF) Nihon Rinsho. Japanese Journal of Clinical Medicine 73(Suppl 9): 145-149
Amarapurkar, D. 2007: Role of liver biopsy in management of chronic hepatitis B and chronic hepatitis C Tropical Gastroenterology: Official Journal of the Digestive Diseases Foundation 28(2): 67-68
Sampliner, R. 1977: Chronic active hepatitis in hepatitis B surface antigen (HBsAg) carriers. the need for liver biopsy JAMA 237(1): 50-51
Rüzgar, M.; Cetin Akhan, S.; Vahaboğlu, H. 2008: Comparison of quantitative hepatitis B virus DNA levels in serum and liver biopsy samples of chronic hepatitis B patients Mikrobiyoloji Bulteni 42(2): 283-291
Baalmann-Mangano, L.; Brunt, E.M. 2003: Evaluating liver disease in chronic hepatitis C--the role of the liver biopsy Medgenmed: Medscape General Medicine 5(3): 21
Endo, H. 1974: Diagnosis of liver cirrhosis by liver biopsy, with special emphasis on the transition from chronic hepatitis Rinsho Byori. Japanese Journal of Clinical Pathology 22(7): 481-488
Tang, Y.H. 1983: The relation of hepatitis B virus to chronic hepatitis, cirrhosis and primary hepatocellar carcinoma--a study of 367 cases of liver biopsy with orcein staining Zhonghua Nei Ke Za Zhi 22(1): 17-20; 62-63
Sarsekeyeva, N.; Kosherova, B.; Tabagari-Bregvadze, N. 2015: Liver Fibrosis in Combined Course of Chronic Hepatitis C and HIV Infection Georgian Medical News 248: 30-34
Gîrleanu, I.; Trifan, A.; Sîngeap, A.M.; Stoica, O.C.; Cojocariu, C.; Stanciu, C. 2016: Platelet Indices and Liver Fibrosis Evaluation in Chronic Hepatitis C Revista Medico-Chirurgicala a Societatii de Medici Si Naturalisti Din Iasi 120(1): 55-61
Zhong, L.-H.; Jiang, Y.-M.; Lou, G.-Q.; Yu, X.-L.; Liu, H.; Guo, J.-C.; Zhu, M.-F.; Xun, Y.-H. 2013: The relationship between serum HBsAg levels and liver inflammation and fibrosis in patients with chronic hepatitis B Zhonghua Shi Yan he Lin Chuang Bing du Xue Za Zhi 27(2): 92-94
Mendes-Correa, M.C.ás.; Widman, A.; Brussi, M.L.P.; Guastini, C.F.át.; Gianini, R.J.é 2008: Incidence and predictors of severe liver fibrosis in HIV-infected patients with chronic hepatitis C in Brazil Aids Patient Care and Stds 22(9): 701-707
Hobstová, J.; Vitous, A. 2011: Viral hepatitis at the beginning of the 21st century--value of liver biopsy in the context of development of new non-invasive diagnostic methods and in relation to the modern therapy of chronic viral hepatitis Ceskoslovenska Patologie 47(2): 44-49
Fierbinteanu-Braticevici, C.; Papacocea, R.; Tribus, L.; Cristian, B. 2014: Role of 13C methacetin breath test for non invasive staging of liver fibrosis in patients with chronic hepatitis C Indian Journal of Medical Research 140(1): 123-129
Levine, R.A.; Ranek, L. 1970: Asymptomatic chronic hepatitis. Correlation between isolated serum transaminase abnormality and liver biopsy Gastroenterology 58(3): 371-378
Macías, J.; Mira, J.é A.; López-Cortés, L.F.; Santos, I.; Girón-González, J.é A.; González-Serrano, M.; Merino, D.; Hernández-Quero, J.é; Rivero, A.; Merchante, N.ás.; Trastoy, M.ón.; Carrillo-Gómez, R.; Arizcorreta-Yarza, A.; Gómez-Mateos, J.ús.; Pineda, J.A. 2006: Antiretroviral therapy based on protease inhibitors as a protective factor against liver fibrosis progression in patients with chronic hepatitis C Antiviral Therapy 11(7): 839-846
Lanini, S.; Bartolini, B.; Taibi, C.; Agresta, A.; Garbuglia, A.R.; Montaldo, C.; Pisapia, R.; D'Offizi, G.; Scognamiglio, P.; Capobianchi, M.R.; Zumla, A.; Ippolito, G. 2019: Early improvement of glycaemic control after virus clearance in patients with chronic hepatitis C and severe liver fibrosis: a cohort study New Microbiologica 42(3): 139-144
Rao, H-ying.; Wei, L.; Li, J.; Zhang, L-fang.; Chen, H-yong.; Zhu, L-min.; Liu, F.; Sun, Y.; Wang, H. 2009: Liver fibrosis and hepatic stellate cells improvement of chronic hepatitis C patients by interferon-beta-1a with or without sustained viral response Hepato-Gastroenterology 56(90): 328-334
Kryczka, W.ła.; Chrapek, M.; Zarebska-Michaluk, D. 2005: Assessment of the usefulness of combination of selected clinical and demographic parameters in prediction of the severity of liver fibrosis in patients with chronic hepatitis C Przeglad Epidemiologiczny 59(2): 395-403